DNLI
Price
$14.96
Change
-$1.73 (-10.37%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
2.42B
63 days until earnings call
NRIX
Price
$13.59
Change
-$0.27 (-1.95%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
1.05B
29 days until earnings call
Ad is loading...

DNLI vs NRIX

Header iconDNLI vs NRIX Comparison
Open Charts DNLI vs NRIXBanner chart's image
Denali Therapeutics
Price$14.96
Change-$1.73 (-10.37%)
Volume$31.75K
Capitalization2.42B
Nurix Therapeutics
Price$13.59
Change-$0.27 (-1.95%)
Volume$12.97K
Capitalization1.05B
DNLI vs NRIX Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. NRIX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and NRIX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (DNLI: $16.69 vs. NRIX: $13.86)
Brand notoriety: DNLI and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 149% vs. NRIX: 81%
Market capitalization -- DNLI: $2.42B vs. NRIX: $1.05B
DNLI [@Biotechnology] is valued at $2.42B. NRIX’s [@Biotechnology] market capitalization is $1.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 6 bearish.
  • NRIX’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а +0.79% price change this week, while NRIX (@Biotechnology) price change was -10.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

DNLI is expected to report earnings on May 13, 2025.

NRIX is expected to report earnings on Jul 10, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.42B) has a higher market cap than NRIX($1.05B). DNLI YTD gains are higher at: -18.106 vs. NRIX (-26.433). NRIX has higher annual earnings (EBITDA): -196.6M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. NRIX (610M). NRIX has less debt than DNLI: NRIX (28.3M) vs DNLI (52.5M). NRIX has higher revenues than DNLI: NRIX (54.5M) vs DNLI (0).
DNLINRIXDNLI / NRIX
Capitalization2.42B1.05B230%
EBITDA-496.05M-196.6M252%
Gain YTD-18.106-26.43368%
P/E RatioN/AN/A-
Revenue054.5M-
Total Cash837M610M137%
Total Debt52.5M28.3M186%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLINRIX
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
79%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MWECX37.070.25
+0.68%
MFS Global Equity C
NWXPX9.550.06
+0.63%
Nationwide International Index Instl Svc
RPFCX61.000.23
+0.38%
Davis Balanced Fund A
APDNX16.380.06
+0.37%
Artisan Select Equity Advisor
VAFCX21.25-0.02
-0.09%
Invesco American Franchise C

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with RCKT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+2.58%
RCKT - DNLI
53%
Loosely correlated
-2.45%
RGNX - DNLI
52%
Loosely correlated
-1.71%
BEAM - DNLI
52%
Loosely correlated
+4.51%
NTLA - DNLI
50%
Loosely correlated
+4.55%
CRSP - DNLI
50%
Loosely correlated
+5.13%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-1.35%
KYMR - NRIX
47%
Loosely correlated
+1.08%
DNLI - NRIX
46%
Loosely correlated
+2.58%
VCYT - NRIX
43%
Loosely correlated
-1.51%
IDYA - NRIX
41%
Loosely correlated
-3.20%
CCCC - NRIX
41%
Loosely correlated
N/A
More